Compass Biotechnologies (OTCBB:COBI) reached up 67.09% in morning trading to $.066 with 2M shares traded. Compass Biotechnologies is a publically-traded specialty biopharmaceutical company with headquarters in Edmonton, Alberta. The mission of Compass is to develop new and exciting recombinant biosimiliar and bio-better drug products that can bring revenue generation to the company in a near term fashion with a significant longer-term upside potential. The Company has also entered into the laboratory research reagents market by initially offering cytokine and cell growth research products. Furthermore, Compass owns an exclusive worldwide license from the National Institutes of Health (NIH) and has opportunities to develop products from the vaccine and immunotherapy platform technology or sub-licensees and other interested partners. Compass Biotech also owns a subsidiary company called C-Pharma, Inc. Compass Biotechnologies (COBI:OB) announced it has entered into an expanded relationship with PanGen Biotech of South Korea, which will allow Compass to offer a globally marketed comprehensive laboratory reagents product line for sale under the Compass Biotech name.
Elite Pharmaceutical, Inc.'s (OTCBB:ELTP) reached up 32% in morning trading to $.099 with 4M shares traded. Elite Pharmaceuticals, Inc. develops oral sustained and controlled release products. Elite's strategy includes assisting partner companies in the life cycle management of products, to improve off-patent drug products, and developing generic versions of controlled release drug products with high barriers to entry. Elite has four ANDA products partnered with TAGI Pharma; one ANDA has launched, two ANDAs are in the process of a manufacturing site transfer and an additional ANDA is currently under review by the FDA. Elite's lead pipeline products, ELI-216, a once-daily abuse resistant oxycodone, and ELI-154, a once-daily oxycodone, are novel sustained release oral formulations of opioids for the treatment of chronic pain, which address two of the limitations of existing oral opioids: the provision of consistent relief of baseline pain levels and deterrence of potential abuse. Elite also has partnered with Mikah Pharma to develop a new product and with Hi-Tech Pharmacal to develop an intermediate for a generic product. Elite also performs contract manufacturing services. Elite operates a GMP and DEA registered facility for research, development, and manufacturing located in Northvale, NJ. Elite Pharmaceutical, Inc.'s (OTCBB:ELTP.OB - News) and ECR Pharmaceuticals ("ECR"), a wholly owned subsidiary of Hi-Tech Pharmacal (Hi-Tech), announced today the launch of Lodrane D(R). Lodrane D(R) is an immediate release formulation of brompheniramine maleate and pseudoephedrine HCl, an effective, low-sedating antihistamine combined with a decongestant.
Liquidmetal® Technologies Inc. (OTCBB: LQMT) reached up 15.26% in morning trading to $.219 with 350K shares traded. Liquidmetal Technologies is a leading supplier of bulk amorphous glass products branded as Liquidmetal. This technology allows innovative companies to replace complex machined parts with injection molded components. In certain applications, this offers stronger, lighter, more corrosion-resistant parts at significantly lower prices. Liquidmetal® Technologies Inc. (OTCBB: LQMT) today announced a strategic partnership with ENGEL AUSTRIA GmbH, the world’s technology leader of injection molding machines with revenues exceeding $800 million for the fiscal year ended March 31, 2011. As pioneers in the development of plastic injection molding technology, ENGEL will now initiate a similar process with the next generation of injection moldable alloys known as Liquidmetal.
For a detailed quote on any of the following companies, or to read the full news articles visit PennyTrader.com
About PennyTrader.com
PennyTrader.com is a financial and investor relations website committed to covering the microcap market space including Pink Sheets and OTC Bulletin Board and sub-$5 big board stocks. We strive to provide you with the best stocks alerts in the market! We focus on OTCBB, OTC, penny stocks, sub-$5 big board stocks, and timely stocks picks and alerts. Our goal is to inform you of the HOTTEST stocks in the market before they move. Our staff has years experience in the stock market, and we are confident that you’ll be impressed with the results of our stock picks! If you wish to feature your organization on our website then you can contact us at publisher@pennytrader.com.
Disclosure: PennyTrader.com is not currently being compensated for any stocks covered in this midday report
PennyTrader.com
is not a registered investment advisers or broker/dealer. PennyTrader.com makes
no recommendation that the purchase of securities of companies profiled in this
press release is suitable or advisable for any person or that an investment
such securities will be profitable. In general, given the nature of the micro
cap companies covered and the potential lack of an active trading market their
securities, investing in such securities is highly speculative and carries a
high degree of risk. For our full disclaimer go to CLICK
HERE
